Novartis Investigative Site

George Town 10050

0 studies enrolling now · 2 studies all time

What they study most

Primary Immune Thrombocytopenia, Primary Immune Thrombocytopenia (ITP)

Studies at this site

• A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids — Running, not enrolling
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling